Expert Mounjaro V Wegovy Dose Analysis - Order Now
Mounjaro V Wegovy Doses: UK Availability Comparison
The key difference when comparing Mounjaro v Wegovy doses lies in their escalation timelines and UK supply reliability. Wegovy follows a structured 16-week titration: 0.25mg (weeks 1-4), 0.5mg (weeks 5-8), 1mg (weeks 9-12), 1.7mg (weeks 13-16), then 2.4mg maintenance. Mounjaro uses a similar escalation but with different dose strengths: 2.5mg, 5mg, 7.5mg, 10mg, and 15mg maximum. Both prescription-only medicines require careful dose escalation to minimise gastrointestinal side effects while optimising therapeutic benefits.
At EverydayMeds, we maintain comprehensive stock levels of both treatments, eliminating the supply shortages that have historically affected weight management medications in the UK. Our GPhC-registered pharmacy #9012878 ensures reliable access to whichever treatment your prescriber recommends. This consistent availability means you can start either medication immediately after clinical approval, without the frustrating delays experienced with other suppliers.
Pricing Breakdown: Mounjaro V Wegovy Doses UK
Understanding the cost implications when comparing Mounjaro v Wegovy doses helps inform your long-term treatment decision. Wegovy pricing starts at £79.99 for the 0.25mg starter dose, progressing to £94.99 (0.5mg), £99.99 (1mg), £139.99 (1.7mg), and £209.99 for the 2.4mg maintenance dose. Our Getting Started bundles provide dose progression convenience: the Intro Duo (0.25mg & 0.5mg) costs £169.99, while the Progress Trio (0.5mg, 1mg & 1.7mg) is priced at £369.99.
New customers benefit from our FIRST40 discount code, with returning patients using DOSE25 - both applied at checkout to reach these final prices. Bundle options like our Ultimate Stability Trio (three 2.4mg pens for £649.99) provide three months of maintenance supply with assured cold-chain storage and delivery. This pricing transparency allows direct comparison with Mounjaro costs, helping you budget effectively for your chosen treatment pathway.
Clinical Evidence: Mounjaro V Wegovy Dose Effectiveness
Research comparing Mounjaro v Wegovy doses demonstrates both medications' efficacy when used alongside a reduced-calorie diet and increased physical activity. Wegovy's STEP 1 trial showed participants achieved approximately 15% average weight loss at 68 weeks with the 2.4mg maintenance dose (Wilding et al., NEJM, 2021). The SELECT cardiovascular outcomes trial revealed a 20% reduction in major cardiovascular events with Wegovy treatment.
Mounjaro's mechanism as a dual GIP/GLP-1 receptor agonist differs from Wegovy's GLP-1-only approach, potentially offering different therapeutic benefits at its higher dose ranges. Both treatments require individualised dose optimisation based on tolerability and clinical response, making direct dose comparisons less meaningful than understanding each medication's complete titration schedule.
How Wegovy Doses Work: GLP-1 Mechanism Explained
Wegovy's dose escalation protocol maximises the GLP-1 receptor agonist mechanism while minimising side effects during treatment initiation. Semaglutide mimics the natural incretin hormone GLP-1, binding to receptors in the brain's appetite control centres and the digestive system. This dual action reduces appetite signals, promotes satiety after smaller meals, and may decrease food cravings throughout the day. The gradual dose increases allow your body to adapt to semaglutide's effects, with each dose strength building therapeutic benefits. Starting at 0.25mg provides initial appetite modulation, while the 2.4mg maintenance dose delivers full clinical efficacy for long-term weight management when combined with lifestyle modifications.
EverydayMeds Ordering Process: Mounjaro V Wegovy Doses
Our streamlined process makes accessing either Mounjaro or Wegovy doses straightforward and professionally managed. Complete our 3-minute online clinical assessment covering your medical history, current medications, and weight management goals - this helps determine which treatment and starting dose suits your circumstances. Your assessment undergoes review by our qualified prescribers (standard 3 working days, or 24-hour express service available), who evaluate both Mounjaro and Wegovy suitability based on MHRA licensing criteria. Once approved, your chosen medication ships via next-day delivery in temperature-controlled packaging, maintaining the cold-chain integrity essential for both treatments. Regular follow-up assessments ensure optimal dose progression and clinical monitoring throughout your treatment journey.
Storage Advantages: Mounjaro V Wegovy Dose Flexibility
Practical storage differences between Mounjaro v Wegovy doses significantly impact treatment convenience and travel flexibility. Wegovy pens remain stable at room temperature (below 30°C) for up to 6 weeks once removed from refrigeration, compared to Mounjaro's 21-day room temperature stability. Both medications require initial storage at 2-8°C and use pre-filled injection pens for once-weekly administration. Wegovy's FlexTouch pen design provides dose accuracy across all five strengths, while the extended room temperature stability makes travel and daily life management more convenient. This storage advantage, combined with Wegovy's established dose escalation protocol, offers practical benefits for long-term treatment adherence and lifestyle integration.
UK Supply Chain: Mounjaro V Wegovy Dose Availability
EverydayMeds maintains robust supply relationships with both Novo Nordisk (Wegovy) and Eli Lilly (Mounjaro), ensuring consistent availability across all dose strengths. Our procurement strategy anticipates demand fluctuations and seasonal variations, preventing the supply interruptions that have affected other weight management medications in the UK market. This reliability means patients can progress through dose escalation schedules without treatment gaps or forced medication switches.
Our inventory management system tracks expiry dates and cold-chain requirements for both Mounjaro and Wegovy doses, guaranteeing fresh stock with maximum stability periods. When comparing Mounjaro v Wegovy doses for availability, patients benefit from our dual-supplier approach and comprehensive stock holding across all licensed dose strengths.
Expert Treatment Selection: Mounjaro V Wegovy Dose Guidance
Both Wegovy and Mounjaro are available from EverydayMeds, with our clinical team helping determine which medication aligns with your treatment goals and medical profile. Your prescriber considers factors including previous weight management attempts, comorbid conditions, medication tolerability, and dose escalation preferences when recommending between these prescription-only medicines. Our 3-minute clinical assessment captures this information efficiently, enabling evidence-based treatment selection. Remember that both medications require commitment to dietary modifications and increased physical activity alongside the prescribed doses. Contact our GPhC-registered pharmacy team for personalised guidance on Mounjaro v Wegovy dose selection and to begin your weight management journey with professional clinical support today.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
